Advancing diabetes remission through primary care and prevention

Eduardo J. Sanchez, MD, MPH, FAHA, chief medical officer for prevention, American Heart Association

“The path we’re on is a sobering path — but it’s also a path that we can change.”

— Dr. Sanchez

Why primary care is central to treating and reversing type 2 diabetes

Type 2 diabetes does not develop in isolation; it exists along a broader continuum of cardiovascular, kidney, and metabolic health. In this expert interview, Dr. Sanchez explains how diabetes fits within a staged framework that begins with ideal cardiovascular health and progresses toward more complex chronic disease. Importantly, this framework is grounded in evidence showing that it is possible to move backward along that continuum, supporting remission and a return toward better health.

Dr. Sanchez emphasizes the critical role of primary care in making this shift possible. As a family physician by training, he highlights that the majority of care for conditions such as hypertension, high cholesterol, and diabetes already occurs in primary care settings. Yet despite its central role, primary care remains under-resourced. Strengthening primary care infrastructure is essential to enabling earlier identification, timely intervention, and the effective delivery of therapeutic lifestyle interventions.

The interview also addresses the cost of inaction. Dr. Sanchez points to national projections showing that the long-term clinical and economic burden of diabetes and related chronic conditions will continue to rise without meaningful change. At the same time, he underscores that this future is not inevitable. By prioritizing prevention, investing in primary care, and advancing evidence-based approaches such as lifestyle medicine, healthcare systems can reduce costs, improve outcomes, and alter the trajectory of chronic disease for individuals and communities alike.

More Expert Interviews

Ed J. Stein, PharmD, MPH, DipACLM, consulting pharmacist, Modern Health Goals

The pharmacist’s role in remission

Josie Bidwell, DNP, RN, FNP-C, DipACLM, FACLM, professor & clinical director, Department of Preventive Director, Office of Well-being, University of Mississippi Medical Center

Rural health solutions

Mahima Gulati, MD, FACE, MSc, DipABLM, FACLM, board certified endocrinologist, UConn Health

The science of remission

Michelle McMacken, MD, FACP, DipABLM, executive director, Nutrition and Lifestyle Medicine, NYC Health + Hospitals

Scaling lifestyle medicine

Wayne Dysinger, MD, MPH, DipABLM, FACLM, chief medical officer, Blue Zones Health

Primary care, reimbursement, and remission

Ori Kochavi, associate chief administration officer, The Permanente Medical Group

The power of lifestyle medicine